A comparison of cefuroxime and co-trimoxazole in severe respiratory tract infections

A comparison of cefuroxime 750 mg 8-hourly im and co-trimoxazole 3 ml 12-hourly im in the treatment of severe respiratory tract infections, was under taken. Twenty patients in each group were treated for at least 5 days with the respective antibiotics. No statistically significant difference was fou...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 1982-06, Vol.9 (6), p.479-484
Main Authors: Mehtar, S., Parr, J. H., Morgan, D. J. R.
Format: Article
Language:English
Subjects:
Adult
Aged
Cefuroxime - administration & dosage
Cefuroxime - adverse effects
Cefuroxime - therapeutic use
Cephalosporins - therapeutic use
Drug Combinations - administration & dosage
Drug Combinations - adverse effects
Drug Combinations - therapeutic use
Female
Humans
Injections, Intramuscular
Male
Middle Aged
Respiratory Tract Infections - drug therapy
Respiratory Tract Infections - microbiology
Sulfamethoxazole - administration & dosage
Sulfamethoxazole - adverse effects
Sulfamethoxazole - therapeutic use
Trimethoprim - administration & dosage
Trimethoprim - adverse effects
Trimethoprim - therapeutic use
Trimethoprim, Sulfamethoxazole Drug Combination
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c353t-2f3fccc77f8b6ad9ba9d1304ddcf78d8bf1d1d9cd645fb8f1733ebb691c7e8913
cites
container_end_page 484
container_issue 6
container_start_page 479
container_title Journal of antimicrobial chemotherapy
container_volume 9
creator Mehtar, S.
Parr, J. H.
Morgan, D. J. R.
description A comparison of cefuroxime 750 mg 8-hourly im and co-trimoxazole 3 ml 12-hourly im in the treatment of severe respiratory tract infections, was under taken. Twenty patients in each group were treated for at least 5 days with the respective antibiotics. No statistically significant difference was found between the two groups.
doi_str_mv 10.1093/jac/9.6.479
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15548465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15548465</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-2f3fccc77f8b6ad9ba9d1304ddcf78d8bf1d1d9cd645fb8f1733ebb691c7e8913</originalsourceid><addsrcrecordid>eNo9kEtLAzEURoMoWh8r18Ks3Mi0STN5LUWsisUXFaSbkEluYHRmUpMZqf56R1pc3cU5fHAPQqcEjwlWdPJu7ESN-bgQageNSMFxPsWK7KIRppjlomD0AB2m9I4x5ozLfbTPlcRSiBFaXGY2NCsTqxTaLPjMgu9jWFcNZKZ1A8y7WDVhbX5CDVnVZgm-IEIWIa2qaLoQv7MuGtsNzIPtqtCmY7TnTZ3gZHuP0OvsenF1m88fb-6uLue5pYx2-dRTb60VwsuSG6dKoxyhuHDOeiGdLD1xxCnreMF8KT0RlEJZckWsAKkIPULnm91VDJ89pE43VbJQ16aF0CdNGCtkwdkgXmxEG0NKEbxeDU-Z-K0J1n8N9dBQK8310HCwz7azfdmA-3e30Qaeb3iVOlj_YxM_NBdUMH37ttRPz4v75cvsRT_QXwVPfwI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15548465</pqid></control><display><type>article</type><title>A comparison of cefuroxime and co-trimoxazole in severe respiratory tract infections</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Mehtar, S. ; Parr, J. H. ; Morgan, D. J. R.</creator><creatorcontrib>Mehtar, S. ; Parr, J. H. ; Morgan, D. J. R.</creatorcontrib><description>A comparison of cefuroxime 750 mg 8-hourly im and co-trimoxazole 3 ml 12-hourly im in the treatment of severe respiratory tract infections, was under taken. Twenty patients in each group were treated for at least 5 days with the respective antibiotics. No statistically significant difference was found between the two groups.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/9.6.479</identifier><identifier>PMID: 6980877</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adult ; Aged ; Cefuroxime - administration &amp; dosage ; Cefuroxime - adverse effects ; Cefuroxime - therapeutic use ; Cephalosporins - therapeutic use ; Drug Combinations - administration &amp; dosage ; Drug Combinations - adverse effects ; Drug Combinations - therapeutic use ; Female ; Humans ; Injections, Intramuscular ; Male ; Middle Aged ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - microbiology ; Sulfamethoxazole - administration &amp; dosage ; Sulfamethoxazole - adverse effects ; Sulfamethoxazole - therapeutic use ; Trimethoprim - administration &amp; dosage ; Trimethoprim - adverse effects ; Trimethoprim - therapeutic use ; Trimethoprim, Sulfamethoxazole Drug Combination</subject><ispartof>Journal of antimicrobial chemotherapy, 1982-06, Vol.9 (6), p.479-484</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-2f3fccc77f8b6ad9ba9d1304ddcf78d8bf1d1d9cd645fb8f1733ebb691c7e8913</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6980877$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mehtar, S.</creatorcontrib><creatorcontrib>Parr, J. H.</creatorcontrib><creatorcontrib>Morgan, D. J. R.</creatorcontrib><title>A comparison of cefuroxime and co-trimoxazole in severe respiratory tract infections</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>A comparison of cefuroxime 750 mg 8-hourly im and co-trimoxazole 3 ml 12-hourly im in the treatment of severe respiratory tract infections, was under taken. Twenty patients in each group were treated for at least 5 days with the respective antibiotics. No statistically significant difference was found between the two groups.</description><subject>Adult</subject><subject>Aged</subject><subject>Cefuroxime - administration &amp; dosage</subject><subject>Cefuroxime - adverse effects</subject><subject>Cefuroxime - therapeutic use</subject><subject>Cephalosporins - therapeutic use</subject><subject>Drug Combinations - administration &amp; dosage</subject><subject>Drug Combinations - adverse effects</subject><subject>Drug Combinations - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Injections, Intramuscular</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Sulfamethoxazole - administration &amp; dosage</subject><subject>Sulfamethoxazole - adverse effects</subject><subject>Sulfamethoxazole - therapeutic use</subject><subject>Trimethoprim - administration &amp; dosage</subject><subject>Trimethoprim - adverse effects</subject><subject>Trimethoprim - therapeutic use</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><recordid>eNo9kEtLAzEURoMoWh8r18Ks3Mi0STN5LUWsisUXFaSbkEluYHRmUpMZqf56R1pc3cU5fHAPQqcEjwlWdPJu7ESN-bgQageNSMFxPsWK7KIRppjlomD0AB2m9I4x5ozLfbTPlcRSiBFaXGY2NCsTqxTaLPjMgu9jWFcNZKZ1A8y7WDVhbX5CDVnVZgm-IEIWIa2qaLoQv7MuGtsNzIPtqtCmY7TnTZ3gZHuP0OvsenF1m88fb-6uLue5pYx2-dRTb60VwsuSG6dKoxyhuHDOeiGdLD1xxCnreMF8KT0RlEJZckWsAKkIPULnm91VDJ89pE43VbJQ16aF0CdNGCtkwdkgXmxEG0NKEbxeDU-Z-K0J1n8N9dBQK8310HCwz7azfdmA-3e30Qaeb3iVOlj_YxM_NBdUMH37ttRPz4v75cvsRT_QXwVPfwI</recordid><startdate>198206</startdate><enddate>198206</enddate><creator>Mehtar, S.</creator><creator>Parr, J. H.</creator><creator>Morgan, D. J. R.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>198206</creationdate><title>A comparison of cefuroxime and co-trimoxazole in severe respiratory tract infections</title><author>Mehtar, S. ; Parr, J. H. ; Morgan, D. J. R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-2f3fccc77f8b6ad9ba9d1304ddcf78d8bf1d1d9cd645fb8f1733ebb691c7e8913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cefuroxime - administration &amp; dosage</topic><topic>Cefuroxime - adverse effects</topic><topic>Cefuroxime - therapeutic use</topic><topic>Cephalosporins - therapeutic use</topic><topic>Drug Combinations - administration &amp; dosage</topic><topic>Drug Combinations - adverse effects</topic><topic>Drug Combinations - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Injections, Intramuscular</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Sulfamethoxazole - administration &amp; dosage</topic><topic>Sulfamethoxazole - adverse effects</topic><topic>Sulfamethoxazole - therapeutic use</topic><topic>Trimethoprim - administration &amp; dosage</topic><topic>Trimethoprim - adverse effects</topic><topic>Trimethoprim - therapeutic use</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mehtar, S.</creatorcontrib><creatorcontrib>Parr, J. H.</creatorcontrib><creatorcontrib>Morgan, D. J. R.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mehtar, S.</au><au>Parr, J. H.</au><au>Morgan, D. J. R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparison of cefuroxime and co-trimoxazole in severe respiratory tract infections</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1982-06</date><risdate>1982</risdate><volume>9</volume><issue>6</issue><spage>479</spage><epage>484</epage><pages>479-484</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>A comparison of cefuroxime 750 mg 8-hourly im and co-trimoxazole 3 ml 12-hourly im in the treatment of severe respiratory tract infections, was under taken. Twenty patients in each group were treated for at least 5 days with the respective antibiotics. No statistically significant difference was found between the two groups.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>6980877</pmid><doi>10.1093/jac/9.6.479</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 1982-06, Vol.9 (6), p.479-484
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_15548465
source Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects Adult
Aged
Cefuroxime - administration & dosage
Cefuroxime - adverse effects
Cefuroxime - therapeutic use
Cephalosporins - therapeutic use
Drug Combinations - administration & dosage
Drug Combinations - adverse effects
Drug Combinations - therapeutic use
Female
Humans
Injections, Intramuscular
Male
Middle Aged
Respiratory Tract Infections - drug therapy
Respiratory Tract Infections - microbiology
Sulfamethoxazole - administration & dosage
Sulfamethoxazole - adverse effects
Sulfamethoxazole - therapeutic use
Trimethoprim - administration & dosage
Trimethoprim - adverse effects
Trimethoprim - therapeutic use
Trimethoprim, Sulfamethoxazole Drug Combination
title A comparison of cefuroxime and co-trimoxazole in severe respiratory tract infections
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A26%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparison%20of%20cefuroxime%20and%20co-trimoxazole%20in%20severe%20respiratory%20tract%20infections&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Mehtar,%20S.&rft.date=1982-06&rft.volume=9&rft.issue=6&rft.spage=479&rft.epage=484&rft.pages=479-484&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/9.6.479&rft_dat=%3Cproquest_cross%3E15548465%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-2f3fccc77f8b6ad9ba9d1304ddcf78d8bf1d1d9cd645fb8f1733ebb691c7e8913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15548465&rft_id=info:pmid/6980877&rfr_iscdi=true